Belite Bio(BLTE) - 2022 Q4 - Annual Report
Belite Bio(BLTE)2023-03-30 16:00
17 The incidence and prevalence for target patient populations of our product candidates are based on estimates and third-party sources. The market opportunities for our product candidates, if approved, may be smaller than we anticipate. The illegal importation of competing products from countries where government price controls or other market dynamics result in lower prices may adversely affect the demand for our future approved product candidates and, in turn, may adversely affect our sales and profitabi ...